Bibliografisk träff 2010-04-27 AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. Grimshaw KM, Hunter LJ, Yap TA, Heaton SP, Walton MI, Woodhead SJ, Fazal L, Reule M, Davies TG, Seavers LC, Lock V, Lyons JF, Thompson NT, Workman P, Garrett MD. Mol Cancer Ther · research support, non-u.s. gov't; research-article; journal article · DOI 10.1158/1535-7163.mct-09-0986